Sign in

Private company

AMERICAN BIO MEDICA CORP

AMERICAN BIO MEDICA CORP is an American pharmaceutical preparations company, incorporated in New York.1 It is headquartered in Kinderhook, New York.1

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersKinderhook, New York1
  • Incorporated inNY2
  • Business address122 Smith Road, Kinderhook, Ny 121062
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-11.3%Gross margin3
-136.0%Operating margin3
-154.4%Net margin3
-58.8%Revenue growth, 20223

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue80¢$1.1M
  • Research and development6¢$85.0K
  • Interest14¢$194.0K
  • Income tax0¢$2.0K

Out of $913.0K in revenue.3 The company lost money this year.

Financial statements

Revenue456783$913.0K in 2022−84% since 2016
0$2.0M$4.0M$6.0M2016: $5.6M$5.6M20162017: $4.9M$4.9M2017−12%2018: $3.9M$3.9M2018−21%2019: $3.7M$3.7M2019−6%2020: $4.1M$4.1M2020+13%2021: $2.2M$2.2M2021−47%2022: $913.0K$913.0K2022−59%
Gross profit456783-$103.0K in 2022
-$1.0M0$1.0M$2.0M$3.0M2016: $2.5M$2.5M20162017: $2.0M$2.0M2017−20%2018: $1.3M$1.3M2018−36%2019: $1.2M$1.2M2019−8%2020: $1.2M$1.2M2020+5%2021: $548.0K$548.0K2021−56%2022: -$103.0K-$103.0K2022
Operating income456783-$1.2M in 2022+383% since 2016
-$1.5M-$1.0M-$500.0K02016: -$257.0K-$257.0K20162017: -$311.0K-$311.0K2017+21%2018: -$762.0K-$762.0K2018+145%2019: -$593.0K-$593.0K2019−22%2020: -$621.0K-$621.0K2020+5%2021: -$1.2M-$1.2M2021+90%2022: -$1.2M-$1.2M2022+5%
Net income456783-$1.4M in 2022+309% since 2016
-$1.5M-$1.0M-$500.0K02016: -$345.0K-$345.0K20162017: -$545.0K-$545.0K2017+58%2018: -$1.0M-$1.0M2018+89%2019: -$681.0K-$681.0K2019−34%2020: -$796.0K-$796.0K2020+17%2021: -$463.0K-$463.0K2021−42%2022: -$1.4M-$1.4M2022+205%
Fiscal year2016201720182019202020212022
Revenue$5.6M4$4.9M5$3.9M6$3.7M7$4.1M8$2.2M3$913.0K3
Cost of revenue$3.1M4$2.9M5$2.6M6$2.5M7$2.9M8$1.7M3$1.1M3
Gross profit$2.5M4$2.0M5$1.3M6$1.2M7$1.2M8$548.0K3-$103.0K3
Research and development$184.0K4$117.0K5$93.0K6$82.0K7$90.0K8$85.0K3$85.0K3
Operating expenses$1.7M3$1.1M3
Operating income-$257.0K4-$311.0K5-$762.0K6-$593.0K7-$621.0K8-$1.2M3-$1.2M3
Interest$284.0K4$272.0K5$284.0K6$265.0K7$175.0K8$194.0K3$194.0K3
Income before tax-$461.0K3-$1.4M3
Income tax$4.0K4$05$2.0K6-$5.0K7$2.0K8$2.0K3$2.0K3
Net income-$345.0K4-$545.0K5-$1.0M6-$681.0K7-$796.0K8-$463.0K3-$1.4M3
Earnings per share-$0.028-$0.018
Shares (weighted, basic)42.8M shares8

Compare AMERICAN BIO MEDICA CORP with another company

Corporate structure

AMERICAN BIO MEDICA CORP sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of AMERICAN BIO MEDICA CORP

  • Stuart Sternberg Filed SC 13G/A on AMERICAN BIO MEDICA CORP, latest Nov 30, 2021 (2 filings since Oct 26, 2021)
  • AMERICAN BIO MEDICA CORP Kinderhook, New York

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What AMERICAN BIO MEDICA CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land$102.0K3 Dec 31, 2022$102.0K3 Dec 31, 20210%
Buildings and improvements$1.4M3 Dec 31, 2022$1.4M3 Dec 31, 20210%
Machinery and equipment$2.1M3 Dec 31, 2022$2.1M3 Dec 31, 20210%
Furniture and fixtures$412.0K3 Dec 31, 2022$412.0K3 Dec 31, 20210%
Property and equipment, before depreciation$4.0M3 Dec 31, 2022$4.0M3 Dec 31, 20210%
Accumulated depreciation$3.5M3 Dec 31, 2022$3.5M3 Dec 31, 2021+1.5%
Property and equipment, net$466.0K3 Dec 31, 2022$517.0K3 Dec 31, 2021−9.9%
Operating-lease assets (leased space)$13.0K3 Dec 31, 2022$40.0K3 Dec 31, 2021−67.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$34.0K3 Dec 31, 2022$115.0K3 Dec 31, 2021−70.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Accumulated amortization$206.0K8 Dec 31, 2021$198.0K8 Dec 31, 2020+4.0%
Finite-lived intangibles, net$08 Dec 31, 2021$108.0K8 Dec 31, 2020−100.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$379.0K3 Dec 31, 2022$443.0K3 Dec 31, 2021−14.4%
Raw materials$444.0K3 Dec 31, 2022$462.0K3 Dec 31, 2021−3.9%
Work in process$110.0K3 Dec 31, 2022$109.0K3 Dec 31, 2021+0.9%
Finished goods$60.0K3 Dec 31, 2022$150.0K3 Dec 31, 2021−60.0%

Leadership

Who has led AMERICAN BIO MEDICA CORP, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Stan Cipkowski2009–2013
  2. Melissa A. Waterhouse2015–2016

President

  1. Edmund M. Jaskiewicz2009–2016

Chief financial officer

  1. Keith E. Palmer2006
  2. Stefan Parker2007–2011
  3. Stan Cipkowski2013
2010201520202025
Board members and other officers (13)

Timeline

  1. Mar 1, 20238-K Completed an acquisition or sale; Executive or director change28
  2. Feb 17, 20238-K Shareholder vote29
  3. Dec 21, 20228-K Entered a material agreement30
  4. Jun 29, 20228-K Shareholder vote31
  5. Mar 14, 20228-K Entered a material agreement32
  6. Dec 22, 20218-K Change of auditor33
  7. Nov 18, 20218-K Results of operations34
  8. Oct 25, 20218-K Entered a material agreement35
  9. Jul 1, 2015New chief executive Melissa A. Waterhouse becomes CEO12
  10. Jul 6, 2009New chief executive Stan Cipkowski becomes CEO13

Calendar

When it reported results

  1. Nov 18, 2021Reported quarterly or annual results34

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

31 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 8 major events, 2 insider forms, 2 large holders, 12 other. The latest 20:

  1. Jul 3, 2025REVOKED EDGAR
  2. Jun 12, 202310-Q EDGAR
  3. May 15, 2023NT 10-Q EDGAR
  4. Mar 21, 202310-K EDGAR
  5. Mar 1, 20238-K EDGAR
  6. Feb 17, 20238-K EDGAR
  7. Jan 13, 2023UPLOAD EDGAR
  8. Jan 11, 2023DEF 14A EDGAR
  9. Jan 5, 2023PRER14A EDGAR
  10. Jan 5, 2023CORRESP EDGAR
  11. Jan 3, 2023UPLOAD EDGAR
  12. Dec 22, 2022PRE 14A EDGAR
  13. Dec 21, 20228-K EDGAR
  14. Nov 16, 202210-Q EDGAR
  15. Nov 14, 2022NT 10-Q EDGAR
  16. Aug 15, 202210-Q EDGAR
  17. Jun 29, 20228-K EDGAR
  18. May 16, 202210-Q EDGAR
  19. Apr 28, 2022DEF 14A SCHEDULE 14A EDGAR
  20. Apr 15, 202210-K EDGAR

The 31 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

  • Stuart SternbergSC 13G/A, 2 filings Oct 26, 2021 to Nov 30, 202136

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$332.1K 2020–2020
Money received by yearMoney received by year, 2020–2020: $332.1K in all. PPP loans $332.1K.$0$100K$200K$300K$400K2020 · PPP loans: $332.1K2020
Figures by year
YearPPP loansTotal
2020$332.1K$332.1K

PPP loans

Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA37. Matched to this company by name and state.

  1. Apr 14, 2020$332.1K PPP loan (first draw) from Pathward National Association37To AMERICAN BIO MEDICA CORPORATION, Kinderhook NY; $336.4K forgiven Aug 4, 2021

SEC filer profile

How AMERICAN BIO MEDICA CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAMERICAN BIO MEDICA CORP1
  • CIK0000896747
  • Employer ID (EIN)14-17021881
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inNew York1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address122 Smith Road, Kinderhook, NY 121061
  • Phone51875881581
  • Shares outstanding48,098,476 as of Jun 12, 202311
  • Public float$867.9K as of Jun 30, 20223
  • On EDGAR sinceNov 21, 19961
  • Filings602 in all: 8-K (144), 4 (129), 10-Q (48), 10QSB (32), DEF 14A (28), 424B3 (26), 10-K (16), 3 (16)1
    All 44 form types

    CORRESP (14), UPLOAD (13), 8-K/A (11), NT 10-K (11), 10KSB (9), 10QSB/A (9), NT 10-Q (9), SC 13G/A (9), SC 13G (8), 5 (7), S-3/A (7), 10KSB/A (5), PRE 14A (5), S-3 (5), EFFECT (4), SB-2 (4), POS AM (3), S-8 (3), 10-K/A (2), 10-Q/A (2), 10KSB40 (2), 10SB12G/A (2), 25-NSE (2), PRER14A (2), RW (2), S-1 (2), SC 13D (2), 10KSB40/A (1), 3/A (1), 8-A12G (1), DEFA14A (1), NT 10-K/A (1), REGDEX (1), REVOKED (1), S-1/A (1), SB-2/A (1)

  • Latest filingsAnnual report (10-K) Mar 21, 2023
    Quarterly report (10-Q) Jun 12, 2023
    Proxy statement (DEF 14A) Jan 11, 2023
    Latest 8-K (8-K) Mar 1, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37